03.06.2020 - 10:00: eleva GmbH [
newsroom]
Freiburg (ots) - Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of Covid-19. The compound, factor H, is part of the complement system, which is believed to affect the ...
To the press release of eleva GmbH